BRANDYWINE MANAGERS, LLC

Holdings History for Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)

Symbol: RLAY on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.16%	0%	$325,109	38,429	0		$8.46	Q4 2025
30 Sep 2025	0.19%	0%	$200,599	38,429	0		$5.22	Q3 2025
30 Jun 2025	0.13%	0%	$132,964	38,429	0		$3.46	Q2 2025
31 Mar 2025	0.12%	0%	$100,684	38,429	0		$2.62	Q1 2025
31 Dec 2024	0.17%	0%	$158,327	38,429	0		$4.12	Q4 2024
30 Sep 2024	0.29%	+0.05%	$272,077	38,429	+6,622	+21%	$7.08	Q3 2024
30 Jun 2024	0.22%	0%	$207,382	31,807	0		$6.52	Q2 2024
31 Mar 2024	0.26%	0%	$263,998	31,807	0		$8.30	Q1 2024
31 Dec 2023	0.38%	0%	$350,195	31,807	0		$11.01	Q4 2023
30 Sep 2023	0.45%	0%	$267,497	31,807	0		$8.41	Q3 2023
30 Jun 2023	0.26%	0%	$399,496	31,807	0		$12.56	Q2 2023
31 Mar 2023	0.37%	0%	$523,861	31,807	0		$16.47	Q1 2023
31 Dec 2022	1.7%	0%	$475,197	31,807	0		$14.94	Q4 2022
30 Sep 2022	2.3%	0%	$712,000	31,807	0		$22.39	Q3 2022
30 Jun 2022	1.3%	+0.26%	$533,000	31,807	+6,382	+25%	$16.76	Q2 2022
31 Mar 2022	1.3%	0%	$761,000	25,425	0		$29.93	Q1 2022
31 Dec 2021	0.88%	+0.13%	$781,000	25,425	+3,702	+17%	$30.72	Q4 2021
30 Sep 2021	0.72%	0%	$685,000	21,723	0		$31.53	Q3 2021
30 Jun 2021	0.91%	+0.07%	$795,000	21,723	+1,771	+8.9%	$36.60	Q2 2021
31 Mar 2021	0.92%	+0.54%	$690,000	19,952	+11,702	+142%	$34.58	Q1 2021
31 Dec 2020	0.47%	0%	$343,000	8,250	0		$41.58	Q4 2020
30 Sep 2020	1.3%	+1.3%	$351,000	8,250	+8,250	NEW	$42.55	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.